Company History and Goals
In early 2016, Drs. Brian A. Logue and Randy Jackson started Analytical and Diagnostic Solutions (ADS) to bring the only rapid (≤60 s) blood cyanide exposure diagnostic to market. Our expertise and research efforts in the analysis of cyanide and its biological metabolites has yielded an academic prototype and continued grant funded research and development yielded a professional prototype. In August 2021, Dr. Jackson became the sole owner of ADS with intentions of expanding ADS's specialty sample analysis services (i.e., forensics, agriculture, environmental, etc.) and contract/novel research capabilities. The main goals of ADS are 1) the advanced development of a cyanide exposure diagnostic towards obtain FDA approval and market entry, 2) to provide quality in all areas of sample analysis, to include reliable results, and 3) to utilize our Analytical Chemistry expertise to solve real world problems for our clients.
We strive to provide analytical and diagnostic solutions through use of current analytical technologies and the development of innovative analytical analysis techniques.
ADS has a skilled team of scientists who have a combined 20+ years of experience in the field of bioanalytical chemistry. Dr. Randy Jackson has developed a rapid and field portable cyanide exposure diagnostic as his dissertation research and has additional biology and forensic science experience. Dr. Jackson is directly involved in the mentorship of future scientists through collaborative research with a wide variety of specialized scientist. Lastly, our research background and wide range of interests enable our team to continually produce innovative technologies and solutions.